Product Information
NORVASC 10 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $11.9416 per EA under NDC 58151035588. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on Jul 31, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the amlodipine besylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151035588
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA019787FDA Approved
7/31/1992
TE Code
AB
On Market Since
2/9/2024
Pharmacological Classes
Price Statistics
The NADAC for NORVASC 10 MG TABLET has been published 131 times since Apr 3, 2024, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.9416 per EA |
|---|---|
| All-time high | $11.9940 (Jul 15, 2026) |
| All-time low | $11.1170 (Dec 18, 2024) |
| 52-week high | $11.9940 |
| 52-week low | $11.2785 |
| Median price | $11.2967 |
| Average price | $11.4436 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORVASC 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORVASC 10 MG TABLET, manufactured by Viatris Specialty LLC, is $11.9416 per EA (NDC 58151035588), effective Sep 30, 2026.
How has the price of NORVASC 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORVASC 10 MG TABLET has risen 6.7%. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for NORVASC 10 MG TABLET?
Since Apr 3, 2024, the NADAC for NORVASC 10 MG TABLET has ranged from a low of $11.1170 (Dec 18, 2024) to a high of $11.9940 (Jul 15, 2026), with a median of $11.2967 per EA.
Are there cheaper alternatives to NORVASC 10 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 10 MG TAB, is $0.0148 per EA — about 99% below NORVASC 10 MG TABLET.
Who manufactures NORVASC 10 MG TABLET?
NORVASC 10 MG TABLET (NDC 58151035588) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.